close 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Investeringen brengen risico`s met zich mee en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

914.01

+1.22%↑

JNJ

235.73

+0.11%↑

ABBV

205.66

+0.7%↑

NVS

148.79

+1.99%↑

AZN

185.14

+0.97%↑

LLY

914.01

+1.22%↑

JNJ

235.73

+0.11%↑

ABBV

205.66

+0.7%↑

NVS

148.79

+1.99%↑

AZN

185.14

+0.97%↑

LLY

914.01

+1.22%↑

JNJ

235.73

+0.11%↑

ABBV

205.66

+0.7%↑

NVS

148.79

+1.99%↑

AZN

185.14

+0.97%↑

LLY

914.01

+1.22%↑

JNJ

235.73

+0.11%↑

ABBV

205.66

+0.7%↑

NVS

148.79

+1.99%↑

AZN

185.14

+0.97%↑

LLY

914.01

+1.22%↑

JNJ

235.73

+0.11%↑

ABBV

205.66

+0.7%↑

NVS

148.79

+1.99%↑

AZN

185.14

+0.97%↑

Home・Aandelen Lijst・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Open

SectorGezondheidszorg

6.98 -6.93

Strong Buy

Prijsupdate 23 mrt 2026, 17:05 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

6.8

Max

7.5

Belangrijke statistieken

By Trading Economics

Inkomsten

-69M

-102M

Verkoop

-10M

34M

EPS

-5.69

Winstmarge

-299.886

Werknemers

228

EBITDA

4.7M

-18M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+155.57% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-267K

157M

Vorige openingsprijs

13.91

Vorige sluitingsprijs

6.98

Nieuwssentiment

By Acuity

67%

33%

300 / 350 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

5.9501 / 7.66 Steun & Weerstand

Karyopharm Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 mrt 2026, 23:50 UTC

Marktinformatie

Global Equities Roundup: Market Talk

DJ

Lezen

22 mrt 2026, 23:50 UTC

Marktinformatie

LG Electronics Set to Stage Strong Earnings Rebound in 1Q -- Market Talk

DJ

Lezen

22 mrt 2026, 23:49 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Gold Edges Lower on Prospects of Liquidity-Driven Sales -- Market Talk

DJ

Lezen

22 mrt 2026, 23:49 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Nikkei May Fall as Concerns About Middle East Conflict Persist -- Market Talk

DJ

Lezen

22 mrt 2026, 23:49 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

22 mrt 2026, 23:41 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Oil Edges Lower as Traders Eye Trump's Deadline to Reopen Strait of Hormuz -- Market Talk

DJ

Lezen

22 mrt 2026, 22:57 UTC

Acquisities, Fusies, Overnames

Perseus Mining: Location of Aurum's Discoveries Present Potential Future Synergies

DJ

Lezen

22 mrt 2026, 22:56 UTC

Acquisities, Fusies, Overnames

Perseus Mining: Aurum Share Acquisition Cost A$23.69 Million

DJ

Lezen

22 mrt 2026, 22:56 UTC

Acquisities, Fusies, Overnames

Perseus Mining: Aurum's Boundiali Gold Project Located to South of Sissingue Gold Mine

DJ

Lezen

22 mrt 2026, 22:55 UTC

Acquisities, Fusies, Overnames

Perseus Mining: Participated in Aurum Resources Equity Raising

DJ

Lezen

22 mrt 2026, 22:54 UTC

Acquisities, Fusies, Overnames

Perseus Mining: Acquires 9.9% Interest in Aurum Resources

DJ

Lezen

22 mrt 2026, 22:22 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

After Selloff, Gold Seen Supported by Strait of Hormuz Deadline -- Market Talk

DJ

Lezen

22 mrt 2026, 22:06 UTC

Acquisities, Fusies, Overnames

Synopsys Has Market Value Over $80 Billion; Major Customers Include Nvidia -- WSJ

DJ

Lezen

22 mrt 2026, 22:06 UTC

Acquisities, Fusies, Overnames

Activist Elliott Builds Big Stake in Chip-Design Software Maker Synopsys -- WSJ

DJ

Lezen

22 mrt 2026, 22:06 UTC

Acquisities, Fusies, Overnames

Activist Elliott Investment Management Has Multibillion-Dollar Investment in Synopsys, Sources Say -- WSJ

DJ

Lezen

22 mrt 2026, 22:06 UTC

Acquisities, Fusies, Overnames

Elliott Plans to Push Synopsys to Make More Money From Its Software and Services, Sources Say -- WSJ

DJ

Lezen

22 mrt 2026, 21:53 UTC

Winsten

Zijin Gold International Plans 59.2 Tons of Gold Production in 2026; up 12.3% on Year >2259.HK

DJ

Lezen

22 mrt 2026, 21:53 UTC

Winsten

Zijin Gold International Rising Gold Prices Supported Results >2259.HK

DJ

Lezen

22 mrt 2026, 21:53 UTC

Winsten

Zijin Gold International 2025 Rev $5.38B Vs. $2.99B >2259.HK

DJ

Lezen

22 mrt 2026, 21:53 UTC

Winsten

Zijin Gold International 2025 Net $1.60B Vs. Net $481.37M >2259.HK

DJ

Lezen

22 mrt 2026, 21:31 UTC

Winsten

China Petroleum & Chemical Plans CNY131.6B-CNY148.6B Capex Spending in 2026>0386.HK

DJ

Lezen

22 mrt 2026, 21:31 UTC

Winsten

China Petroleum & Chemical: Decrease in Sales Volumes of Refined Oil Products Also Hurt Results >0386.HK

DJ

Lezen

22 mrt 2026, 21:31 UTC

Winsten

China Petroleum & Chemical 2025 Results Weighed by Decrease in Prices of Petroleum, Petrochemical Products>0386.HK

DJ

Lezen

22 mrt 2026, 21:31 UTC

Winsten

China Petroleum & Chemical 2025 Rev CNY2.78T Vs. CNY3.07T >0386.HK

DJ

Lezen

22 mrt 2026, 21:31 UTC

Winsten

China Petroleum & Chemical 2025 Net CNY32.48B Vs. Net CNY48.94B >0386.HK

DJ

Lezen

22 mrt 2026, 21:25 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Bonds Decoupling From Oil Amid Longer Conflict Fears -- Market Talk

DJ

Lezen

22 mrt 2026, 21:22 UTC

Acquisities, Fusies, Overnames

St Barbara: Remarks Follow Recent Inquiries About Simberi's Fuel Stocks

DJ

Lezen

22 mrt 2026, 21:21 UTC

Acquisities, Fusies, Overnames

St Barbara: Simberi Currently Uses About 65,000 Liters Per Day For Mining Fleet, Power Generation

DJ

Lezen

22 mrt 2026, 21:21 UTC

Marktinformatie

Revised Fuel Subsidy Mechanism Positive for Ampol, Viva Energy -- Market Talk

DJ

Lezen

22 mrt 2026, 21:21 UTC

Acquisities, Fusies, Overnames

St Barbara: Has Been Taking Precaution to Increase Diesel Storage For Several Months

DJ

Lezen

Peer Vergelijking

Prijswijziging

Karyopharm Therapeutics Inc Prognose

Koersdoel

By TipRanks

155.57% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 19.5 USD  155.57%

Hoogste 28 USD

Laagste 12 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Karyopharm Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Gebaseerd op 5 analisten die aandelenratings hebben gegeven aan Karyopharm Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

5.9501 / 7.66Steun & Weerstand

Korte Termijn

Bullish Evidence

Recent bullish events outweigh bearish events.

Gemiddeld Termijn

Strong Bearish Evidence

All events are bearish.

Lange Termijn

No Evidence

There are no events.

Sentiment

By Acuity

300 / 350 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

914.01

↑ +1.22%

JNJ

Johnson and Johnson

235.73

↑ +0.11%

ABBV

AbbVie Inc

205.66

↑ +0.7%

NVS

Novartis AG

148.79

↑ +1.99%

AZN

AstraZeneca PLC

185.14

↑ +0.97%
help-icon Live chat